KannelWB. The Framingham Study: its 50-year legacy and future promise. J Atheroscler Thrombos. 2000;6(2):60–66.
2.
BreslowLBreslowN. Health practices and disability: some evidence from Alameda County. Prev Med. 1993;22:86–95.
3.
McKeownTThe Role of Medicine: Dream, Mirage, or Nemesis?London: Nuffield Provincial Hospitals Trust; 1976.
4.
MarmotMWilkinsonRG, eds Social Determinants of Health. New York: Oxford; 1999.
5.
US Department of Health and Human ServicesTrends in the Well-being of America's Children and Youth 2000. Washington, DC: US Government Printing Office; 2000.
US Department of Health and Human ServicesHealthy People 2010. Washington, DC: US Dept of Health and Human Services; 2000:16.27, 16.28.
8.
US Department of Health and Human ServicesHealthy People 2010. Washington, DC: US Dept of Health and Human Services; 2000:12.21.
9.
DaniasPGO'MahonySRadfordMJ. Serum cholesterol levels are underevaluated and undertreated. Am J Cardiol. 1998;81:1353–1356.
10.
GilesWHAndaRFWilliamsonDF. Recent trends in the identification and treatment of high blood cholesterol by physicians: progress and missed opportunities. JAMA. 1993;269:1133–1138.
11.
MarksJSLeeNC. Implementing recommendations for the early detection of breast and cervical cancer among low-income women. MMWR. 2000;49:35–55.
12.
US Department of Health and Human ServicesHealthy People 2010. Washington, DC: US Dept of Health and Human Services; 2000:3.25.
13.
Office on Smoking and Health. Achievements in public health, 1900–1999: tobacco use—United States, 1900–1999. MMWR. 1999;48:986–994.
14.
OrleansCTCummingsKM. Population-based tobacco control: progress and prospects. Am J Health Promot. 1999;14:83–91.
15.
MokdadASerdulaMKDietzWH. The spread of the obesity epidemic in the United States, 1991–1998. JAMA. 1999;282:1519–1522.
16.
US Department of Health and Human ServicesPhysical Activity and Health: A Report of the Surgeon General. Atlanta, GA: US Dept of Health and Human Services; 1996.
17.
Mercer/Foster Higgins. Report 1997. National Survey of Employer-sponsored Health Plans. New York: Mercer/Foster Higgins; 1997. Cited by: Partnership for Prevention. Why Invest in Disease Prevention?: Results from the Partnership for Prevention/William M. Mercer Survey of Employer-sponsored Health Plans. Washington, DC; 1999.
18.
US Preventive Services Task ForceGuide to Clinical Preventive Services. 2nd ed.Baltimore, MD: Williams & Wilkins; 1996.
19.
US Department of Health and Human ServicesHealthy People 2010. Washington, DC: US Dept of Health and Human Services; 2000:8.19.
20.
US Department of Health and Human ServicesFor a Healthy Nation: Returns on Investment in Public Health. Washington, DC: US Dept of Health and Human Services; 1994.
21.
National Center for Health Statistics and National Center for Environmental Health. Update: blood lead levels—United States, 1991–1994. MMWR. 1997;46:141–146.
22.
Office of Lead Hazard Control. National Survey of Lead and Allergens in Housing: Final Report. Volume I: Analysis of Lead Hazards. Washington, DC: US Dept of Housing and Urban Development. Available at: http://www.hud.gov/lea/Vol1finalreport.pdf. Accessed January 31, 2001.
23.
OrleansCTBarkerDCKaufmanNJMarxJF. Helping pregnant smokers quit: meeting the challenge in the next decade. Tobacco Control. 2000;9(Suppl):iii6–iii11.
24.
US Department of Health and Human Services. Healthy People 2010. Washington, DC: US Dept of Health and Human Services; 2000:15.4.
25.
Partnership for Prevention. Why Invest in Disease Prevention?: Results from the Partnership for Prevention/William M. Mercer Survey of Employer Sponsored Health Plans. Washington, DC; 1999.
26.
WhiteCCKoplanJPOrensteinWA. Benefits, risks, and costs of immunization for measles, mumps, and rubella. Am J Public Health. 1985;75:739–744.
27.
US Department of Health and Human ServicesFor a Healthy Nation: Returns on Investment in Public Health. Washington, DC: US Dept of Health and Human Services; 1994.
28.
HowellMRQuinnTCGaydosCA. Screening for chlamydia trachomatis in asymptomatic women attending family planning clinics: a cost-effectiveness study of three strategies. Ann Intern Med. 1998;128:277–284.
29.
AldanaS. Financial impact of health promotion programs: a comprehensive review of the literature. Am J Health Promot. 2001;15:296–320.
30.
BunkerJPFrazierHSMostellerF. Improving health: measuring effects of medical care. Milbank Q. 1994;72:225–258.
31.
BrownRCoreaJLuceB. Effectiveness in disease and injury prevention estimated national spending on prevention—United States, 1988. MMWR. 1992;41:529–531.
32.
HCFA Office of the Actuary. National health expenditures, by source of funds and type of expenditure: selected calendar years 1993–1998. http://www.lzhcfa.gov/stats/NHE-OAct/tables/t3.htm. Accessed December 5, 2000.
HadornDC. Setting health care priorities in Oregon: cost-effectiveness meets the rule of rescue. JAMA. 1991;265:2218–2225.
35.
LevitKRLazenbyHCBradenBR. National health expenditures, 1996. Health Care Financ Rev. 1997;19:161–200.
36.
MedderJDKahnNBSusmanJL. Risk factors and recommendations for 230 adult primary care patients, based on US Preventive Services Task Force guidelines. Am J Prev Med. 1992;8:150–153.
37.
McGinnisJMFoegeWH. Actual causes of death in the United States. JAMA. 1993;270:2207–2212.
38.
US Department of Agriculture, Economic Research Service. Expenditures for tobacco products and disposable personal income, 1990–1999. Available at: http://www.ers.usda.gov/briefing/tobacco/Data/table20.pdf. Accessed February 5, 2001.
39.
Adams Wine Handbook 2000. New York: Adams Business Media; 2000:31.
40.
US Department of Agriculture, Economic Research Service, Food and Consumer Economics DivisionFood Marketing Review, 1994–1995. Agricultural Economic Report No. 743. Washington, DC: US Dept of Agriculture; 1996.
